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Abstract: We present a case of diabetic macular edema in a pregnant patient treated with a 
single intravitreal injection of triamcinolone acetonomide. Initial presentation and serial exami-
nations after treatment included visual acuity, slit-lamp examination, indirect ophthalmoscopy, 
and optical coherence tomography. Resolution of visual acuity and macular edema were present 
six weeks after injection and persisted throughout the duration of the pregnancy without further 
intervention. No adverse outcomes for either mother or fetus were noted. To our knowledge, 
this is the first report of intravitreal triamcinolone administration in this patient population to 
be published in the medical literature.
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Case report
A pregnant 23-year-old female with a six-year history of  Type 1 diabetes presented with 
a complaint of increased “blur” in both eyes for the previous two months. Her most 
recent hemoglobin A1c was measured at 6.4%. She was six months’ pregnant at initial 
presentation. On examination her best corrected visual acuity was 20/40 OU. Slit-lamp 
examination was entirely unremarkable in both eyes. Dilated funduscopic examination 
was significant for flame-shaped, dot, and blot hemorrhages in the posterior segment, 
with associated macular edema and exudates bilaterally (Figures 1A and 1B). No   retinal 
neovascularization was noted. Optical coherence tomography (OCT) revealed a foveal 
thickness of 578 ± 5 microns and 667 ± 8 microns in the right and left eye, respectively 
(Figures 2A and 2B). All OCT scans were performed with the Stratus® optical coher-
ence tomograph (Zeiss-Humphrey Inc, Dublin, CA).
Examination findings were consistent with bilateral, nonproliferative diabetic retin-
opathy and clinically significant macular edema. After careful deliberation with the patient 
and her obstetrician, a decision was made to treat the bilateral macular edema with intra-
vitreal triamcinolone acetonide injection. The patient received 0.05 mL of triamcinolone 
acetonide 40 mg/mL in the left eye initially and in the right eye one week later.
The patient returned for re-examination six weeks after treatment. Best-corrected 
visual acuity was 20/20 and 20/25 in the right and left eye, respectively. Funduscopic 
examination revealed marked reduction in macular edema bilaterally. Repeat OCT 
revealed a foveal thickness of 159 ± 5 microns and 202 ± 6 microns in the right and 
left eye, respectively (Figures 3A and 3B).
Four months after treatment, the patient’s visual acuity remained stable   bilaterally. 
Slit-lamp examination and Goldman applanation tonometry did not reveal any Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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  intraocular hypertension or significant lenticular changes 
at this visit or at any point after triamcinolone injection. 
  Funduscopic examination revealed only mild retinal thicken-
ing in the left eye. The patient delivered a full-term, healthy 
baby boy weeks prior to this examination. The patient 
reported no complications in pregnancy or parturition.
Discussion
Progression of diabetic retinopathy during pregnancy has 
been described previously by several authors.1,2 Visual 
impairment in these cases can result from both proliferative 
(eg, vitreous hemorrhage, retinal detachment) and nonpro-
liferative etiologies (eg, retinal hemorrhage, papillopathy, 
macular edema).1 Although macular edema may regress in 
some cases after delivery, in other cases edema can persist 
and can be associated with severe and persistent visual 
dysfunction.1
Data from large, randomized clinical trials have estab-
lished the benefits of argon laser photocoagulation for clini-
cally significant macular edema.3 Focal laser   photocoagulation 
of actively leaking blood vessels or grid laser for areas of 
Figure 1 A) Color fundus photograph of the right eye. B) Color fundus photograph 
of the left eye.
Figure 2 A) Optical coherence tomograph of macula at initial presentation, right eye. 
B) Optical coherence tomograph of macula at initial presentation, left eye.
Figure  3  A)  Optical  coherence  tomograph  of  macula  at  six  weeks  following 
injection,  right  eye.  B)  Optical  coherence  tomograph  of  macula  at  six  weeks 
following injection, left eye.Clinical Ophthalmology
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diffuse permeability can decrease clinically significant edema. 
However, laser photocoagulation in close proximity to the 
fovea increases the risk of inducing iatrogenic central scotoma 
as a result of thermal injury to the tissues, or subsequent glial 
proliferation.
There are many reports of off-label use of intravitreal 
triamcinolone in cases of persistent and refractory diabetic 
macular edema.4 Improved visual acuity and decreased 
foveal thickness have been documented by serial OCT after 
a single injection. However, these effects do not appear to 
persist beyond 3–4 months without repeated administration.5 
A Medline search using keywords “pregnancy”,   “pregnant”, 
“clinically significant macular edema”, “gestational   diabetes”, 
and “triamcinolone acetonide” revealed no case reports or 
case series documenting the treatment of clinically significant 
macular edema with intravitreal corticosteroids in a pregnant 
patient.
Side effects of systemic corticosteroid administration 
are well known. Major ophthalmic complications of intra-
vitreal corticosteroid injection include, but are not limited 
to, cataract formation and increased intraocular pressure. 
Although corticosteroid equivalents can be measured in the 
aqueous three months after a single intravitreal injection, it 
is not known how much corticosteroid is released into the 
systemic circulation after a single intravitreal injection.6 
Thus, it is hard to estimate the systemic effects of intravitreal 
corticosteroid therapy.
To date, there are no reports of teratogenic outcomes 
with systemic corticosteroid use in pregnant human females. 
However, teratogenic effects have been observed in many 
species receiving equivalent systemic human doses.7 Many 
authors have noted maxillofacial deformity and, in   particular, 
cleft palate in mice which have received corticosteroids early 
in gestation.
Our patient presented with bilateral clinically significant 
diabetic macular edema and diminishing vision. The area of 
greatest thickening was within the fovea of both the right and 
left eyes, with little edema observed in the extrafoveal area. 
Laser photocoagulation to this area carried a significant risk 
of inducing a permanent central scotoma. We consulted the 
patient’s obstetrician about the possibility of initiating intra-
vitreal corticosteroid therapy. Given the patient’s late stage 
of pregnancy, we felt that intravitreal steroid posed little risk 
to either mother or fetus. We were able to achieve  resolution 
of macular edema and improved visual acuity with a single 
intravitreal dose to each eye.
In conclusion, we propose that intravitreal triamcinolone 
injection may be a viable treatment modality for management 
of clinically significant macular edema in pregnant patients. 
The safety profile with administration of this medication is 
enhanced if the steroid is administered after the first trimester. 
We suggest a multidisciplinary approach and consultation 
with an obstetrician whenever using corticosteroid therapy 
in pregnant patients.
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